MedPath

COVID-19 Self-testing IMPROVE

Not Applicable
Completed
Conditions
COVID-19
Registration Number
NCT06576167
Lead Sponsor
Temple University
Brief Summary

The study aims to engage community partners to implement IMPROVE intervention and promote (COVID-19) rapid testing among vulnerable Asian Americans in the Greater Philadelphia Area and New York City

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1271
Inclusion Criteria
  • (1) self-identified as Asian from one of the subgroups: Chinese, Korean, Vietnamese, Filipino, or other South Asian Americans,
  • (2) aged 18 and above,
  • (3) living in the Greater Philadelphia or NYC areas,
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
the change in the rate of COVID-19 self-testingbaseline, 1-month follow up, and 3-month follow up
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center for Asian Health, Lewis Katz School of Medicine, Temple University

🇺🇸

Philadelphia, Pennsylvania, United States

Center for Asian Health, Lewis Katz School of Medicine, Temple University
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.